日韩午夜精品视频,欧美私密网站,国产一区二区三区四区,国产主播一区二区三区四区

--- SEARCH ---
WEATHER
CHINA
INTERNATIONAL
BUSINESS
CULTURE
GOVERNMENT
SCI-TECH
ENVIRONMENT
SPORTS
LIFE
PEOPLE
TRAVEL
WEEKLY REVIEW
Film in China
War on Poverty
Learning Chinese
Learn to Cook Chinese Dishes
Exchange Rates
Hotel Service
China Calendar
Trade & Foreign Investment

Hot Links
China Development Gateway
Chinese Embassies

Tongrentang Starts New Facility Operations

Two new production bases of Beijing Tongrentang, a leading producer of traditional Chinese medicines (TCM), are to officially start operations at the end of this year.

 

"The completion of the new production bases is a key step in Tongrentang's further development and for the modernization of the TCM industry," said Mei Qun, general manager of Beijing Tongrentang Group.

 

The bases, to be located in Yizhuang, Beijing Economic Development Area, will accommodate eight large-scale TCM production lines and involve a total investment of nearly 600 million yuan (US$72.5 million).

 

"Streamlined production will greatly increase output and meet the huge market demand," Mei said.

 

Tongrentang's products are popular among Chinese consumers. According to the company's statistics, on average, the supplies of some 30 kinds of products run out everyday.

 

One production base, owned by Tongrentang's Shanghai-listed subsidiary Tongrentang Shareholding Co, has a designed annual capacity of 1.5 million kilograms of pill medicines, 200 million capsules, 600 million drop pellets, and 400,000 kilograms of granules.

 

The other, invested in by Hong Kong-listed Tongrentang Technologies Co, can produce 3 billion tablets, 4 million kilograms granules and 3 million kilograms pills a year.

 

Industry insiders said that Tongrentang's new production bases mean the company has shifted focus from traditional manufacture to modernized large-scale production.

 

In addition to its production expansion in Beijing, Tongrentang also plans to set up a TCM manufacturing base outside the Chinese mainland, to serve its overseas business.

 

Beijing Tongrentang Guoyao Co Ltd announced late last month that it would invest HK$150 million (US$19 million) in setting up a plant in Hong Kong.

 

"Using the region's geographic and transportation advantages, we can better develop products for overseas markets," Mei said.

 

He said he expected that the Hong Kong production base's annual output could reach 500 million yuan (US$60.4 million) in 2005 and top 1 billion yuan (US$120 million) in three years.

 

Tongrentang, which celebrated its 335th anniversary this year, has set an ambitious goal of achieving a total sales of 30 billion yuan (US$4.8 billion) and net profit of 1.3 billion yuan (US$157 million) by the year 2011.

 

(China Daily November 18, 2004)

Herbal Drugs to Be Standardized
Traditional Chinese Medicine Eyes Int'l Market
Famous Medicine Company Lands in Seoul
A Herb a Day Keeps Doctors Away
Standards to Be Set for TCM
Tongrentang to Introduce Environmental Friendly Prescription
Print This Page
|
Email This Page
About Us SiteMap Feedback
Copyright © China Internet Information Center. All Rights Reserved
E-mail: webmaster@china.org.cn Tel: 86-10-68326688
主站蜘蛛池模板: 兴国县| 诸暨市| 民乐县| 凤冈县| 简阳市| 桐城市| 电白县| 兰溪市| 喜德县| 苍梧县| 阿克苏市| 霍城县| 海宁市| 青岛市| 柳林县| 罗源县| 新沂市| 内江市| 大新县| 新巴尔虎右旗| 巴塘县| 罗平县| 泰和县| 新巴尔虎右旗| 新巴尔虎左旗| 格尔木市| 连州市| 定西市| 正阳县| 武定县| 介休市| 瑞金市| 中方县| 遂宁市| 水富县| 贵阳市| 丰城市| 大同市| 景德镇市| 徐州市| 四川省|